Tian Zhang, Director of Clinical Research at UT Southwestern Medical Center, shared a ASCO‘s post on X:
“Always love hearing Sumanta K. Pal distill all of metastatic kidney cancer treatment in 15 mins. New treatments of bispecifics, T cell engagers and CART cells. Society of Urologic Oncology annual meeting kicks off with kidney cancer course.”
More posts about Kidney Cancer on OncoDaily.